April 7, 2020
Medical diagnostic company Fluxergy, founded by UC San Diego engineering alumni, submitted an Emergency Use Authorization to the FDA for their quick, point-of-care COVID-19 test.
January 22, 2021
With the third week of winter quarter underway at the University of California San Diego, COVID-19 case rates have fallen dramatically since classes resumed on Jan. 4. The current test positivity rate on campus has reduced to pre-break levels of less than 1%.
April 17, 2020
Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.
June 9, 2021
UC San Diego School of Medicine researchers discovered that SARS-CoV-2, or at least its genetic signature, abounds on hospital surfaces, often co-locating with one particular type of bacteria.
March 23, 2021
Investigators from UC San Diego and UCLA report COVID-19 infection rates for a cohort of health care workers previously vaccinated for the novel coronavirus. Risk of infection is minuscule, but exists.
May 5, 2020
Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.
May 24, 2021
The University of California San Diego has received the 2021 American Council of Education/Fidelity Investments Award for Institutional Transformation for its science-based, real-time approach to maintaining a low infection rate among students, faculty and staff on campus during the pandemic.
June 17, 2020
Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.
June 11, 2021
UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies — for current and future pandemics.
March 22, 2023
UC San Diego researchers describe why SARS-CoV-2 subvariants spread more rapidly than the original virus strain, and how an early treatment might have made people more susceptible to future infections.
